OTCMKTS:GTBIF Q4 EPS Estimate Lowered by Roth Capital

Green Thumb Industries Inc. (OTCMKTS:GTBIF) – Research analysts at Roth Capital dropped their Q4 2025 earnings per share estimates for Green Thumb Industries in a report issued on Thursday, November 6th. Roth Capital analyst W. Kirk now anticipates that the company will post earnings per share of $0.00 for the quarter, down from their prior estimate of $0.02. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share. Roth Capital also issued estimates for Green Thumb Industries’ Q1 2026 earnings at $0.01 EPS, Q2 2026 earnings at $0.02 EPS and FY2026 earnings at $0.07 EPS.

Several other equities research analysts also recently issued reports on the company. Zacks Research downgraded Green Thumb Industries from a “hold” rating to a “strong sell” rating in a report on Friday, October 10th. Canaccord Genuity Group raised shares of Green Thumb Industries to a “strong-buy” rating in a research report on Thursday, October 9th. Finally, Benchmark restated a “buy” rating on shares of Green Thumb Industries in a research note on Monday, August 11th. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Green Thumb Industries currently has a consensus rating of “Buy”.

Green Thumb Industries Trading Up 7.3%

Shares of OTCMKTS GTBIF opened at $6.98 on Friday. The company has a market capitalization of $1.45 billion, a P/E ratio of 41.08 and a beta of 1.18. Green Thumb Industries has a 12 month low of $4.63 and a 12 month high of $10.49. The stock has a 50 day moving average of $7.85 and a 200-day moving average of $6.73.

Green Thumb Industries (OTCMKTS:GTBIF) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.01. Green Thumb Industries had a return on equity of 1.66% and a net margin of 3.77%.The firm had revenue of $291.37 million for the quarter, compared to analyst estimates of $290.98 million.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.